Procter & Gamble vs Honeywell
Global consumer staples giant with diverse household brands vs Diversified industrial technology group with aerospace and building businesses. Which is the better buy for your portfolio in August 2026? Plain-English answer below.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and commercial customers who buy on performance, not habit. Both companies are large-cap industrials-adjacent businesses with decades of dividend growth and pricing power, but their end-market dynamics differ sharply. The Procter & Gamble vs Honeywell comparison reveals how brand loyalty economics and industrial technology value propositions translate into distinctly different earnings growth trajectories.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and ...
Why It’s Moving
P&G is moving on mixed results, cautious guidance, and a push into wellness
- P&G’s latest quarterly report showed earnings per share slightly ahead of expectations, but revenue missed, keeping the focus on margin discipline rather than top-line growth.
- The company paired that update with a cautious outlook for fiscal 2027, signaling modest sales growth and a sizable cost headwind that is tempering enthusiasm.
- Shares have also been reacting to analyst debate after recent rating cuts and a takeover move into supplements, which highlights both valuation concerns and P&G’s push to expand beyond traditional staples.
HON slips as analysts lean cautious on Honeywell’s post-spin growth story
- Analysts have turned more cautious after a string of target cuts and hold calls, signaling that the market is still recalibrating Honeywell’s growth outlook after the recent aerospace separation.
- Honeywell’s latest leadership updates in Automation and Process Technology suggest management is still reshaping the portfolio, but investors appear focused on whether those changes can offset softer near-term momentum.
- The stock has also been pressured by the post-spin weakness in Honeywell Aerospace, which has weighed on sentiment across the broader Honeywell story and kept expectations muted.
P&G is moving on mixed results, cautious guidance, and a push into wellness
- P&G’s latest quarterly report showed earnings per share slightly ahead of expectations, but revenue missed, keeping the focus on margin discipline rather than top-line growth.
- The company paired that update with a cautious outlook for fiscal 2027, signaling modest sales growth and a sizable cost headwind that is tempering enthusiasm.
- Shares have also been reacting to analyst debate after recent rating cuts and a takeover move into supplements, which highlights both valuation concerns and P&G’s push to expand beyond traditional staples.
HON slips as analysts lean cautious on Honeywell’s post-spin growth story
- Analysts have turned more cautious after a string of target cuts and hold calls, signaling that the market is still recalibrating Honeywell’s growth outlook after the recent aerospace separation.
- Honeywell’s latest leadership updates in Automation and Process Technology suggest management is still reshaping the portfolio, but investors appear focused on whether those changes can offset softer near-term momentum.
- The stock has also been pressured by the post-spin weakness in Honeywell Aerospace, which has weighed on sentiment across the broader Honeywell story and kept expectations muted.
Investment Analysis
Pros
- Procter & Gamble has a strong global presence with a diversified portfolio including beauty, grooming, healthcare, and household care segments.
- Analysts maintain a consensus 'Buy' rating with an average price target suggesting a potential 19-20% upside over the next year.
- The company has consistent dividend payments, making it attractive for income-focused investors seeking steady returns.
Considerations
- Recent insider selling has raised concerns about future performance and may indicate cautious sentiment from key executives.
- The stock currently trades at a relatively high price-to-earnings ratio compared to its earnings potential, suggesting possible overvaluation.
- Procter & Gamble’s stock price has shown volatility with fluctuations between approximately $147 and $180 over the last year, which might deter risk-averse investors.
Honeywell
HON
Pros
- Honeywell reported robust Q2 2025 earnings that exceeded estimates and raised its adjusted EPS guidance for the year.
- The company’s aerospace division is a key growth driver, considered undervalued by analysts and poised for higher valuation multiples.
- Recent strategic moves, including acquisitions and a planned three-way corporate split, aim to unlock value and enhance shareholder returns.
Considerations
- Honeywell’s stock trades at a higher price-to-book ratio relative to sector averages, implying a premium valuation that may limit upside.
- The company operates in cyclical industrial sectors, exposing it to macroeconomic fluctuations that could affect performance.
- Execution risks remain around the announced corporate restructuring and the integration of recent acquisitions, which could impact near-term results.
next-earnings-date-heading
The next expected earnings date for PG is October 23, 2026. This report should cover fiscal Q1 2027. Based on the company’s historical reporting pattern, the announcement is typically expected in late October and before the market opens.
next-earnings-date-heading
The next earnings date for HON is expected on October 22, 2026. It is typically based on Honeywell’s historical reporting pattern and has not yet been formally confirmed. The report should cover Q3 2026 results. For an investor briefing, that places the release in the usual late-October window for the company.
next-earnings-date-heading
The next expected earnings date for PG is October 23, 2026. This report should cover fiscal Q1 2027. Based on the company’s historical reporting pattern, the announcement is typically expected in late October and before the market opens.
next-earnings-date-heading
The next earnings date for HON is expected on October 22, 2026. It is typically based on Honeywell’s historical reporting pattern and has not yet been formally confirmed. The report should cover Q3 2026 results. For an investor briefing, that places the release in the usual late-October window for the company.
Buy PG or HON in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
